| __timestamp | Taro Pharmaceutical Industries Ltd. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 91733000 | 4241601.57 |
| Thursday, January 1, 2015 | 87644000 | 5392385.38 |
| Friday, January 1, 2016 | 92365000 | 7370036.73 |
| Sunday, January 1, 2017 | 85656000 | 14970357 |
| Monday, January 1, 2018 | 88196000 | 31413266 |
| Tuesday, January 1, 2019 | 89971000 | 72279461 |
| Wednesday, January 1, 2020 | 93413000 | 183907682 |
| Friday, January 1, 2021 | 91355000 | 307644000 |
| Saturday, January 1, 2022 | 113676000 | 472132000 |
| Sunday, January 1, 2023 | 198366000 | 709539000 |
| Monday, January 1, 2024 | 218935000 |
Data in motion
In the competitive pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Taro Pharmaceutical Industries Ltd. and argenx SE have showcased contrasting strategies. Taro's SG&A expenses have remained relatively stable, averaging around $113 million annually, with a notable increase of 92% from 2014 to 2023. In contrast, argenx SE has seen a dramatic rise, with expenses skyrocketing by over 16,600% from 2014 to 2023, reflecting its aggressive growth strategy. While Taro's consistent approach suggests a focus on efficiency, argenx's escalating costs highlight its investment in expansion and innovation. The data for 2024 is incomplete, leaving room for speculation on future trends. As these companies navigate the evolving market, their SG&A management will be pivotal in determining their financial health and competitive edge.
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: argenx SE vs Intra-Cellular Therapies, Inc.
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? argenx SE or Pharming Group N.V.
Operational Costs Compared: SG&A Analysis of argenx SE and Viking Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.